Final eligibility is determined during provider evaluation
Only 11.2% of participants stopped the trial due to side effects, and the discontinuation rate dropped significantly after week 24, suggesting those who make it through the early phase generally tolerate it well long-term
The convenience of its capsule-based form and its easy integration into a daily routine empower users to support their body's natural processes without resorting to injections, prescriptions, or synthetic chemicals
Higher-End Protocol (Intensive Research): In some specific, intensive research scenarios, dosages might go up to 1,000 mcg (1 mg) per day, usually split into two 500 mcg doses
Most patients tolerate lipotropic injections very well
our free reconstitution calculator works out the concentration and syringe draw for any vial size